Shield Therapeutics plc

Shield Therapeutics plc is a commercial-stage specialty pharmaceutical company focused on developing and commercializing clinical-stage pharmaceuticals for unmet medical needs. Its lead product is Accrufer/Feraccru (ferric maltol), a non-salt oral therapy for iron deficiency, with or without anemia. The company was incorporated in 2008 and is based in Gateshead, United Kingdom.